Jane Street
SLDB icon

Jane Street’s Solid Biosciences SLDB Stock Holding History

Jane Street’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-53,200
Closed -$383K – 12991
2026
Q1 		$383K Buy
+53,200
New +$342K ﹤0.01% 8653
2021
Q3 		– Sell
-1,820
Closed -$100K – 10644
2021
Q2 		$100K Sell
1,820
-2,480
-58% -$164K ﹤0.01% 9263
2021
Q1 		$357K Buy
4,300
+3,533
+461% +$391K ﹤0.01% 7417
2020
Q4 		$87K Buy
+767
New +$48.5K ﹤0.01% 7237

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's SLDB Position: Q2 2026 in Review

Jane Street reduced its Solid Biosciences (SLDB) stake by 36% in Q2 2026, selling an estimated $267K and leaving 61,786 shares worth $617K. The position accounts for ﹤0.01% of the portfolio, ranked #7536.

Jane Street first reported a position in SLDB in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.2M in Q4 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Jane Street held 61,786 shares of Solid Biosciences worth $617K as of Q2 2026.
  • Jane Street sold 35,207 Solid Biosciences shares in Q2 2026, an estimated $267K.
  • Solid Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7536 holding.
  • Jane Street first reported a position in Solid Biosciences in Q2 2020 and has held it in 11 quarters since.
  • Jane Street's Solid Biosciences position peaked at $1.2M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.